Financials

  • Market Capitalization 45.01 M
  • Employee 20
  • Founded 1971
  • CEO N/A
  • Website www.verupharma.com
  • Headquarter Wisconsin, United States
  • FIGI BBG000G12J78
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.45
Rapporto prezzo/fatturato
12.31

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4297
CNTX
Context Therapeutics Inc. - Common Stock
0.50 USD-3.85%-5.66%-18.03%-43.82%45.94 M USD
4300
MCRB
Seres Therapeutics, Inc. - Common Stock
4.56 USD-0.22%+0.22%-8.43%-44.59%45.33 M USD
4310
KPTI
Karyopharm Therapeutics Inc. - Common Stock
1.96 USD+7.69%-2.97%-73.69%-79.67%44.46 M USD
4315
TVGN
Tevogen Bio Holdings Inc. - Common Stock
6.75 USD+5.97%+2.43%+48.03%+625.81%43.95 M USD

Notizie